Bread Supplemented With Chilean Beans to Decrease Postprandial Glycoxidative Responses: A Pilot Intervention
Formulación de Productos de panificación Suplementados Con Harina de Porotos Nativos Chilenos Para Disminuir Respuestas glicémicas Postprandiales y agregación Plaquetaria en Personas Mayores: Un Estudio Piloto
1 other identifier
interventional
25
1 country
1
Brief Summary
The goal of this trial is to assess in healthy subjects between 60 and 70 years the effect of glycemic and glycoxidative postprandial responses and platelet aggregation after intake of bread supplemented with Chilean beans flour when compared with a non supplemented control. The main questions to answer are:
- It is possible to decrease postprandial glycemic and glycoxidative responses by means of the intake of bread supplemented with Chilean beans flour when compared to the intake of a control bread non supplemented in healthy elderly persons?
- How is affected the platelet aggregation process during postprandial state after intake of bread supplemented with Chilean beans flour, when compared to the intake of a control bread non supplemented in healthy elderly persons? Participants will:
- Be characterized by means of: 1) evaluation of body composition, using anthropometric techniques, bioimpedance and 2) biochemical analyses: biochemical profile, lipid profile, serum ferritin, fasting glycemia, HbA1c and insulin.
- Arrive at fast to the laboratory and eat randomly control bread, 30% Chilean beans supplemented bread or glucose. Venous blood samples will be taken from the cubital fossa of the dominant arm at: 0, 30, 60 and 120 min postprandial, only after intake of bread control and supplemented bread. In addition, capillary blood will be taken at 0, 15, 30, 60, 90 and 120 min postprandial after intake of glucose, bread control or supplemented bread.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2023
CompletedFirst Submitted
Initial submission to the registry
June 27, 2023
CompletedFirst Posted
Study publicly available on registry
July 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedJuly 21, 2023
July 1, 2023
25 days
June 27, 2023
July 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the postprandial levels of methylglyoxal in plasma
Determiantion of the change in the levels of methylglyoxal in plasma by means of pre-column derivatization and posterior separation, detection and quantification by means of high performance liquid chromatography and detection by fluorescence
0, 30, 60 and 120 min postprandial
Study Arms (3)
Control Bread
OTHERSubjects will eat control bread, in an amount containing 50g of carbohydrates
Bread Supplemented with Chilean Beans
EXPERIMENTALSubjects will eat bread supplemented with Chilean native beans at 30% w/w, in an amount containing 50g of carbohydrates
Glucose control
OTHERSubjects will drink glucose, in an amount containing 50g of carbohydrates
Interventions
Volunteers will arrive at fasting and blood samples (aprox. 5mL) will be obtained before (0 min) and after the intake (10 min of intake) an amount of control bread containing 50g of carbohydrates, venous blood samples for determination of insulin, methyglyoxal, 3-deoxyglucosone and platelet aggregation will be collected at 30, 60, 90 and 120 mn postprandial. In addition, capillary slood will be obtained at 0, 15, 30, 60, 90 and 120 postprandial for glycemia determination
Volunteers will arrive at fasting and blood samples (aprox. 5mL) will be obtained before (0 min) and after the intake (10 min of intake) an amount of supplemented bread containing 50g of carbohydrates, venous blood samples for determination of insulin, methyglyoxal, 3-deoxyglucosone and platelet aggregation will be collected at 30, 60, 90 and 120 mn postprandial. In addition, capillary slood will be obtained at 0, 15, 30, 60, 90 and 120 postprandial for glycemia determination.
Volunteers will arrive at fasting and capillary blood samples will be obtained before (0 min) and after the intake an amount of control glucose containing 50g of this monosscharide (10 min of intake), capillary slood will be also obtained at 15, 30, 60, 90 and 120 postprandial for glycemia determination.
Eligibility Criteria
You may qualify if:
- Persons between 60-70 years old.
- Persons autonomous.
- Persons who are willing to participate in this study and who have agreed and signed the informed consent.
You may not qualify if:
- Clinical diagnosis of diabetes
- Persons with levels of glycosylated hemoglobin (HbA1c) lhigher than 6.5
- Clinical diagnosis and uncontrolled chronic diseases.
- Anemia, dtermined by ferritin levels less than 15 µg/ L.
- Oropharyngeal disorders (self-reported).
- Persons with gastric bypass surgery.
- Celiac disease (self-reported).
- Coagulation disorders (self-reported).
- Use of medications that modify the glycemic response or lipid profile (acarbose, thiazolinediones, metformin, insulin, orlistat, among others).
- Clinical diagnosis of Alzheimer's disease or sinile dementia.
- People with pacemakers or metal subcutaneous implants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Talcalead
- Interuniversity Center for Healthy Agingcollaborator
- Centro de Estudios en Alimentos Procesadoscollaborator
- Clínica Fleming de Talcacollaborator
Study Sites (1)
School of Nutrition and Dietetics
Talca, 3460000, Chile
Study Officials
- PRINCIPAL INVESTIGATOR
Felipe Ávila, PhD
School of Nutrition and Dietetics, Health Sciences Faculty, University of Talca
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Blood samples will be codified, and the keys will be saved by Felipe Ávila. The personal in charge of the blood analyses (quantification of methylglyoxal and 3-deoxyglucosone) will register their results using the codes and therefore will not know the type of sample analyzing or the volunteer that provided the sample.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asociate Professor
Study Record Dates
First Submitted
June 27, 2023
First Posted
July 21, 2023
Study Start
May 5, 2023
Primary Completion
May 30, 2023
Study Completion
April 30, 2024
Last Updated
July 21, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share
This was not authorized by the Institutional Ethics Comitee